HSPE1P9

Across TCGA pan-cancer cohorts, HSPE1P9 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated HSPE1P9 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher HSPE1P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HSPE1P9 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

MESO, THYM, and UVM are the cancer types where HSPE1P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.198	0.412	<.001	93	view →
THYM	DFS	Tertile	III,IV	0.197	0.934	<.001	60	view →
UVM	OS	Tertile	All	0.136	0.919	<.001	45	view →
LGG	DFS	Tertile	All	0.591	0.768	<.001	45	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	39	view →
SKCM	DFS	Tertile	IV	0.168	0.525	.021	33	view →
HNSC	OS	Tertile	II,III,IV	0.499	0.733	.008	27	view →
STAD	OS	Tertile	II,III,IV	0.539	0.810	.003	24	view →
ACC	DFS	Quartile	All	0.359	0.643	.005	23	view →
LIHC	OS	Tertile	III,IV	0.218	0.603	<.001	18	view →
UCEC	OS	Quartile	II,III,IV	0.781	0.876	.025	10	view →
LUSC	OS	Quartile	III,IV	0.360	0.836	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

HSPE1P9–MESO (DFS)

Open the MESO breakdown →